AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 22, 2024 -- Artificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication, plastic, and cost, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.
Noting that eye drops in ophthalmology clinics have artificial expiration dates of 14 and 28 days, John M. Tan, from the New York Eye and Ear Infirmary of Mount Sinai in New York City, and colleagues collected multiuse ophthalmic drops planned to be discarded at three ophthalmology clinics over three 14-day study periods. The volume of residual medication, and waste in terms of plastic and cost were measured and extrapolated to one year.
The researchers found that 297 bottles were discarded over six weeks of collection. On average, 71.9 percent of medication remained and bottles were discarded 494 days before expiration listed by the manufacturer. Ninety-one percent of bottles would have been completely used by the manufacturer's expiration date based on medication usage frequency. Due to artificial expiration dates, each exam lane wasted an extra $1,328 in costs, 207 g of plastic (30 medication bottles), and 11,881 drops per year.
"We were really surprised by just how much medication was being wasted," Tan said in a statement. "We hope that clinics and providers use the FDA-regulated expiration date printed on each bottle. Considering the frequent medication shortages we have to contend with, this is one simple way to reduce the strain on our supply of ophthalmic medications."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-23 12:00
Read more
- Reporting of Human Adenoviruses Has Declined Since COVID-19
- Tolebrutinib Designated Breakthrough Therapy by the FDA for Non-Relapsing Secondary Progressive Multiple Sclerosis
- Rilzabrutinib Demonstrated Significant Patient Benefit in the First Positive Phase 3 Study of a BTK Inhibitor in ITP
- Newer Epilepsy Meds Safe During Pregnancy, Won't Affect Kids' Neurodevelopment
- U.S. Overdose Deaths Linked to Fentanyl May Be Declining
- Guidelines Developed for Treatment of Restless Legs Syndrome
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions